Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic

Bibliografiska uppgifter
Huvudupphovsmän:	McGregor, CG, Adams, A, Sadler, R, Arancibia-Cárcamo, CV, Palmer, R, Ambrose, T, Brain, O, Walsh, A, Klenerman, P, Travis, SP, Croft, NM, Lindsay, JO, Satsangi, J
Materialtyp:	Journal article
Språk:	English
Publicerad:	BMJ Publishing Group 2021

Beskrivning
Sammanfattning:

Liknande verk